Clinical Trials Directory

Trials / Completed

CompletedNCT01367587

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

Safety and Gastrointestinal Effects of Multiple-Dosed Intravenous Methylnaltrexone in Healthy Human Volunteers

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Bausch Health Americas, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study evaluates the safety of multiple doses of IV MNTX in normal healthy adults.

Conditions

Interventions

TypeNameDescription
DRUGIV Methylnaltrexone

Timeline

Start date
2002-04-01
Primary completion
2002-07-01
Completion
2002-07-01
First posted
2011-06-07
Last updated
2019-11-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01367587. Inclusion in this directory is not an endorsement.

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone (NCT01367587) · Clinical Trials Directory